185 related articles for article (PubMed ID: 35443668)
1. Epidemiology of neuroendocrine neoplasmas in Japan: based on analysis of hospital-based cancer registry data, 2009 - 2015.
Koizumi T; Otsuki K; Tanaka Y; Kanda S
BMC Endocr Disord; 2022 Apr; 22(1):105. PubMed ID: 35443668
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological analysis of lung and mediastinal neuroendocrine neoplasms in Japan based on the national database.
Matsuoka S; Koizumi T; Otsuki K; Tanaka Y; Kanda S; Ide S; Mishima S; Takeda T; Miura K; Eguchi T; Hamanaka K; Shimizu K
Cancer Epidemiol; 2022 Apr; 77():102116. PubMed ID: 35144127
[TBL] [Abstract][Full Text] [Related]
3. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
Masui T; Ito T; Komoto I; Uemoto S;
BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
[TBL] [Abstract][Full Text] [Related]
4. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.
Garcia-Carbonero R; Sorbye H; Baudin E; Raymond E; Wiedenmann B; Niederle B; Sedlackova E; Toumpanakis C; Anlauf M; Cwikla JB; Caplin M; O'Toole D; Perren A;
Neuroendocrinology; 2016; 103(2):186-94. PubMed ID: 26731334
[No Abstract] [Full Text] [Related]
5. National incidence and initial therapy for thymic carcinoma in Japan: based on analysis of hospital-based cancer registry data, 2009-2015.
Koizumi T; Otsuki K; Tanaka Y; Noguchi T; Fukushuima T; Kobayashi T; Ozawa T; Sekiguchi N; Hamanaka K
Jpn J Clin Oncol; 2020 Apr; 50(4):434-439. PubMed ID: 32134448
[TBL] [Abstract][Full Text] [Related]
6. Incidence and relative survival of pancreatic adenocarcinoma and pancreatic neuroendocrine neoplasms in Germany, 2009-2018. An in-depth analysis of two population-based cancer registries.
Stang A; Wellmann I; Holleczek B; Fell B; Terner S; Lutz MP; Kajüter H
Cancer Epidemiol; 2022 Aug; 79():102204. PubMed ID: 35777306
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and survival outcomes of colorectal mixed neuroendocrine-non-neuroendocrine neoplasms and neuroendocrine carcinoma.
Suraju MO; Freischlag K; Jacob D; Thompson D; Mckeen A; Tran C; Sherman SK; Goffredo P; Weigel RJ; Hassan I
Surgery; 2024 Mar; 175(3):735-742. PubMed ID: 37867105
[TBL] [Abstract][Full Text] [Related]
8. Nationwide registry for patients with neuroendocrine neoplasm of pancreas, gastrointestinal tract, lungs, bronchi, or thymus in Japan.
Masui T; Ito T; Komoto I; Kojima S; Kasai Y; Tanabe M; Hara K; Hirano S; Okusaka T; Ichikawa Y; Kinugasa Y; Kokudo N; Kudo A; Sakurai A; Sugihara K; Date H; Haruma K; Hijioka S; Hirata K; Yamano H; Sakamine M; Kikuchi T; Fukushima M; Imamura M; Uemoto S
Int J Clin Oncol; 2022 May; 27(5):840-849. PubMed ID: 35178624
[TBL] [Abstract][Full Text] [Related]
9. The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan.
Ito T; Lee L; Hijioka M; Kawabe K; Kato M; Nakamura K; Ueda K; Ohtsuka T; Igarashi H
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):574-7. PubMed ID: 25689058
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
12. [Registry of neuroendocrine tumors (NET) in Czech Republic after three years of data collection].
Vítek P; Strenková J; Sedláčková E; Barkmanová J; Mužík J; Louthan O
Klin Onkol; 2013; 26(4):271-80. PubMed ID: 23961858
[TBL] [Abstract][Full Text] [Related]
13. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).
Garcia-Carbonero R; Capdevila J; Crespo-Herrero G; Díaz-Pérez JA; Martínez Del Prado MP; Alonso Orduña V; Sevilla-García I; Villabona-Artero C; Beguiristain-Gómez A; Llanos-Muñoz M; Marazuela M; Alvarez-Escola C; Castellano D; Vilar E; Jiménez-Fonseca P; Teulé A; Sastre-Valera J; Benavent-Viñuelas M; Monleon A; Salazar R
Ann Oncol; 2010 Sep; 21(9):1794-1803. PubMed ID: 20139156
[TBL] [Abstract][Full Text] [Related]
14. Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops.
Eriksson J; Norlén O; Ögren M; Garmo H; Ihre-Lundgren C; Hellman P
Scand J Surg; 2021 Mar; 110(1):44-50. PubMed ID: 31587594
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
16. Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study.
Zhang X; Ma L; Bao H; Zhang J; Wang Z; Gong P
BMC Endocr Disord; 2014 Jul; 14():54. PubMed ID: 25001493
[TBL] [Abstract][Full Text] [Related]
17. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.
Sorbye H; Baudin E; Perren A
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724
[TBL] [Abstract][Full Text] [Related]
18. Belgian guidelines for pathology reporting of neuroendocrine neoplasms of the pancreaticobiliary and gastrointestinal tract.
Hoorens A; Borbath I; Vandamme T; Verslype C; Demetter P; Cuyle PJ; Ribeiro S; Van Damme N; Geboes KP
Acta Gastroenterol Belg; 2023; 86(2):345-351. PubMed ID: 37428168
[TBL] [Abstract][Full Text] [Related]
19. Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources.
Darbà J; Marsà A
BMC Cancer; 2019 Dec; 19(1):1226. PubMed ID: 31842791
[TBL] [Abstract][Full Text] [Related]
20. Trends in diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in India: A report of multicenter data from a web-based registry.
Palepu J; Shrikhande SV; Bhaduri D; Shah RC; Sirohi B; Chhabra V; Dhar P; Sastry R; Sikora S
Indian J Gastroenterol; 2017 Nov; 36(6):445-451. PubMed ID: 29457213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
